BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19225548)

  • 1. Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured rats.
    Miyazato M; Sugaya K; Goins WF; Wolfe D; Goss JR; Chancellor MB; de Groat WC; Glorioso JC; Yoshimura N
    Gene Ther; 2009 May; 16(5):660-8. PubMed ID: 19225548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of detrusor-sphincter dyssynergia by herpes simplex virus vector mediated gene delivery of glutamic acid decarboxylase in spinal cord injured rats.
    Miyazato M; Sugaya K; Saito S; Chancellor MB; Goins WF; Goss JR; de Groat WC; Glorioso JC; Yoshimura N
    J Urol; 2010 Sep; 184(3):1204-10. PubMed ID: 20663524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological changes in different populations of bladder afferent neurons detected by herpes simplex virus (HSV) vectors with cell-type-specific promoters in mice with spinal cord injury.
    Shimizu N; Doyal MF; Goins WF; Kadekawa K; Wada N; Kanai AJ; de Groat WC; Hirayama A; Uemura H; Glorioso JC; Yoshimura N
    Neuroscience; 2017 Nov; 364():190-201. PubMed ID: 28942324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in detrusor-sphincter dyssynergia by bladder-wall injection of replication-defective herpes simplex virus vector-mediated gene delivery of kynurenine aminotransferase II in spinal cord injury rats.
    Wang Z; Liao L
    Spinal Cord; 2017 Feb; 55(2):155-161. PubMed ID: 27995942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus vector-mediated gene transfer of kynurenine aminotransferase improves detrusor overactivity in spinal cord-injured rats.
    Jia C; Yoshimura N; Liao L
    Gene Ther; 2014 May; 21(5):484-9. PubMed ID: 24598891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Transfer of Glutamic Acid Decarboxylase 67 by Herpes Simplex Virus Vectors Suppresses Neuropathic Pain Induced by Human Immunodeficiency Virus gp120 Combined with ddC in Rats.
    Kanao M; Kanda H; Huang W; Liu S; Yi H; Candiotti KA; Lubarsky DA; Levitt RC; Hao S
    Anesth Analg; 2015 Jun; 120(6):1394-404. PubMed ID: 25851180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA receptor activation in the lumbosacral spinal cord decreases detrusor overactivity in spinal cord injured rats.
    Miyazato M; Sasatomi K; Hiragata S; Sugaya K; Chancellor MB; de Groat WC; Yoshimura N
    J Urol; 2008 Mar; 179(3):1178-83. PubMed ID: 18206170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain.
    Liu J; Wolfe D; Hao S; Huang S; Glorioso JC; Mata M; Fink DJ
    Mol Ther; 2004 Jul; 10(1):57-66. PubMed ID: 15233942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of urethral wall injection of replication-defective herpes simplex virus-mediated gene transfer of kynurenine aminotransferase on urethral pressure in spinal cord-injured rats.
    Wang Z; Liao L
    Neurourol Urodyn; 2017 Apr; 36(4):1046-1051. PubMed ID: 27391207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus vector mediated gene therapy of tumor necrosis factor-α blockade for bladder overactivity and nociception in rats.
    Funahashi Y; Oguchi T; Goins WF; Gotoh M; Tyagi P; Goss JR; Glorioso JC; Yoshimura N
    J Urol; 2013 Jan; 189(1):366-73. PubMed ID: 23174234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception.
    Yokoyama H; Oguchi T; Goins WF; Goss JR; Nishizawa O; de Groat WC; Wolfe D; Krisky DM; Glorioso JC; Yoshimura N
    Hum Gene Ther; 2013 Feb; 24(2):170-80. PubMed ID: 23316929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats.
    Majima T; Funahashi Y; Takai S; Goins WF; Gotoh M; Tyagi P; Glorioso JC; Yoshimura N
    Hum Gene Ther; 2015 Nov; 26(11):734-42. PubMed ID: 26204493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel synthesis and release of GABA in cerebellar granule cell cultures after infection with defective herpes simplex virus vectors expressing glutamic acid decarboxylase.
    New KC; Gale K; Martuza RL; Rabkin SD
    Brain Res Mol Brain Res; 1998 Oct; 61(1-2):121-35. PubMed ID: 9795182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception.
    Oguchi T; Funahashi Y; Yokoyama H; Nishizawa O; Goins WF; Goss JR; Glorioso JC; Yoshimura N
    Gene Ther; 2013 Feb; 20(2):194-200. PubMed ID: 22402319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of herpes simplex virus vector-mediated gene therapy of protein phosphatase 1α on bladder overactivity and nociception.
    Majima T; Mori K; Kadekawa K; Takai S; Funahashi Y; Reinhart B; Goins WF; Gotoh M; Glorioso JC; Yoshimura N
    Neurourol Urodyn; 2019 Feb; 38(2):582-590. PubMed ID: 30499116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy.
    Sasaki K; Chancellor MB; Goins WF; Phelan MW; Glorioso JC; de Groat WC; Yoshimura N
    Diabetes; 2004 Oct; 53(10):2723-30. PubMed ID: 15448108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin.
    Yokoyama H; Sasaki K; Franks ME; Goins WF; Goss JR; de Groat WC; Glorioso JC; Chancellor MB; Yoshimura N
    Hum Gene Ther; 2009 Jan; 20(1):63-71. PubMed ID: 20377371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of endothelin-A receptor antagonist on bladder overactivity in rats with chronic spinal cord injury.
    Ogawa T; Sasatomi K; Hiragata S; Seki S; Nishizawa O; Chermansky CJ; Pflug BR; Nelson JB; Chancellor MB; Yoshimura N
    Urology; 2008 Feb; 71(2):341-5. PubMed ID: 18308116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats.
    Coelho A; Oliveira R; Cruz F; Cruz CD
    Exp Neurol; 2016 Nov; 285(Pt B):159-166. PubMed ID: 27235935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vector-mediated gene transfer to express inhibitory neurotransmitters in dorsal root ganglion reduces pain in a rodent model of lumbar radiculopathy.
    Lee JY; Fink DJ; Mata M
    Spine (Phila Pa 1976); 2006 Jun; 31(14):1555-8. PubMed ID: 16778687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.